Press Release Prime Medicine Reports Second Quarter 2026 Financial Results and Provides Business Updates Aug 6
Press Release Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease Jul 23